BioAtla (BCAB) Other financing activities (2020 - 2026)
BioAtla's (BCAB) quarterly Other financing activities came in at $289000.0 in Q1 2026, down 21.04% year-on-year from $366000.0 in Q1 2025, and up 445.28% quarter-over-quarter from $53000.0 in Q4 2025.
BioAtla (BCAB) Other financing activities (2020 - 2026) Analysis & Trends
BioAtla's Other financing activities history runs 7 years deep, the most recent figure standing at $289000.0 for Q1 2026.
- On a quarterly basis, Other financing activities fell 21.04% year-over-year to $289000.0 in Q1 2026; TTM through Mar 2026 was $23000.0, a 96.75% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 70.76% from the prior year.
- Other financing activities grew to $289000.0 in Q1 2026 per BCAB's latest filing, from $53000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $366000.0 in Q1 2025 and bottomed at -$397000.0 in Q3 2025.
- The 5-year median for Other financing activities is $149000.0 (2023), against an average of $105818.2.
- Biggest YoY gain for Other financing activities was 129.53% in 2024; the steepest drop was 1842.86% in 2024.
- Year by year, Other financing activities stood at $270000.0 in 2022, then tumbled by 44.81% to $149000.0 in 2023, then surged by 129.53% to $342000.0 in 2024, then plunged by 84.5% to $53000.0 in 2025, then jumped by 445.28% to $289000.0 in 2026.
- Per Business Quant, the three latest BCAB Other financing activities figures stand at $289000.0 (Q1 2026), $53000.0 (Q4 2025), and -$397000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | -397,000.00 |
| Sep 30, 2025 | -397,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 342,000.00 |
| Dec 31, 2024 | 342,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Dec 31, 2023 | 149,000.00 |
| Dec 31, 2023 | 149,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |